Literature DB >> 16401577

Microentrapment of probiotic bacteria in a Ca(2+)-induced whey protein gel and effects on their viability in a dynamic gastro-intestinal model.

A Ainsley Reid1, J C Vuillemard, M Britten, Y Arcand, E Farnworth, C P Champagne.   

Abstract

Entrapping probiotic bacteria in gels with ionic cross-linking is typically achieved with polysaccharides (alginate, pectin, carraghenan). In this study, whey proteins were used for this purpose by carrying out the Ca(2+)-induced gelation of pre-heated whey protein isolate (WPI). A Lactobacillus rhamnosus cell suspension was added in a denatured WPI solution in a 30 : 70 volume ratio. Gelation was carried out by extrusion of the cell suspension in a CaCl(2) solution. Beads of approximately 3 mm diameter were formed. The population in the beads was 8.0 x 10(8) cells g(-1). Entrapment efficiency in gel beads was 96%, with a survival level of 23%. Scanning electron microscopy of beads before freeze-drying showed a tight protein network containing encapsulated Lb. rhamnosus cells homogeneously distributed throughout the matrix. The survival to freeze-drying of the bead-entrapped cells was 41%. Viability of microentrapped cells in a dynamic gastro-intestinal (GI) model was studied and the results were compared to free cells freeze-dried in a milk-based cryoprotective solution, as well as in a pre-denatured WPI solution. Results showed that protein gelation provided protection against acidic conditions in the stomach after 90 min, as well as against bile after 30, 60 and 90 min in the duodenum. Moreover, the milk-based cryoprotective solution was equally effective after 90 min in the duodenum. It is concluded that the gelation of whey proteins induced by Ca(2+) ions can protect the cells against adverse conditions of the GI system. However, certain stages in the entrapment process, particularly extrusion in the solution of CaCl(2), still need to be optimized in order to reduce the mortality of the cells during gelation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401577     DOI: 10.1080/02652040500162840

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  13 in total

1.  Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans.

Authors:  Stéphanie Blanquet-Diot; Sylvain Denis; Sandrine Chalancon; Fehd Chaira; Jean-Michel Cardot; Monique Alric
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

2.  The influence of different polymers on viability of Bifidobacterium lactis 300b during encapsulation, freeze-drying and storage.

Authors:  Oana Lelia Pop; Thorsten Brandau; Jens Schwinn; Dan Cristian Vodnar; Carmen Socaciu
Journal:  J Food Sci Technol       Date:  2014-07-08       Impact factor: 2.701

3.  Encapsulation of R. planticola Rs-2 from alginate-starch-bentonite and its controlled release and swelling behavior under simulated soil conditions.

Authors:  Zhansheng Wu; Lina Guo; Shaohua Qin; Chun Li
Journal:  J Ind Microbiol Biotechnol       Date:  2011-08-31       Impact factor: 3.346

Review 4.  Materials Used for the Microencapsulation of Probiotic Bacteria in the Food Industry.

Authors:  Ewa Kowalska; Małgorzata Ziarno; Adam Ekielski; Tomasz Żelaziński
Journal:  Molecules       Date:  2022-05-21       Impact factor: 4.927

5.  Increased intestinal delivery of viable Saccharomyces boulardii by encapsulation in microspheres.

Authors:  Sandrine Graff; Sajjad Hussain; Jean-Claude Chaumeil; Christine Charrueau
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

6.  Cryoprotective effect of turanose on lyophilized Lactobacillus paracasei subsp. paracasei, L. casei 431.

Authors:  Dong-Joo Han; Su-Jin Jun; Byung-Hoo Lee; Sang-Ho Yoo
Journal:  Food Sci Biotechnol       Date:  2022-01-31       Impact factor: 2.391

Review 7.  The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells.

Authors:  Satya Prakash; Catherine Tomaro-Duchesneau; Shyamali Saha; Arielle Cantor
Journal:  J Biomed Biotechnol       Date:  2011-07-02

Review 8.  Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent.

Authors:  Himanshu K Solanki; Dipak D Pawar; Dushyant A Shah; Vipul D Prajapati; Girish K Jani; Akil M Mulla; Prachi M Thakar
Journal:  Biomed Res Int       Date:  2013-08-21       Impact factor: 3.411

9.  Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.

Authors:  Jasmine Bhathena; Christopher Martoni; Arun Kulamarva; Catherine Tomaro-Duchesneau; Meenakshi Malhotra; Arghya Paul; Aleksandra Malgorzata Urbanska; Satya Prakash
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

Review 10.  Immobilization technologies in probiotic food production.

Authors:  Gregoria Mitropoulou; Viktor Nedovic; Arun Goyal; Yiannis Kourkoutas
Journal:  J Nutr Metab       Date:  2013-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.